Since our data demonstrated that IKAROS represses expression of the MTOR gene, we tested the effect of IKAROS expression on sensitivity to rapamycin treatment in B-ALL. The gene discussed is MTOR; the disease is precursor B-cell acute lymphoblastic leukemia.